Business Practice

Discovery & Development Drug Discovery

06/01/2023 | Jamie Irvine | 5 min read

Day One Bio commits to creating purposeful treatments for children with life-threatening diseases

Business & Regulation Business Practice

05/30/2023 | Stephanie Vine | 2 min read

Amgen’s planned acquisition of Horizon Therapeutics has hit a bump in the road.

Discovery & Development Drug Discovery

05/22/2023 | Jamie Irvine | 2 min read

Thermo Fisher Scientific and UCSF launch new cell therapy manufacturing site to accelerate advanced cell therapies development

Business & Regulation Business Practice

05/11/2023 | Mallikarjun Chityala | 5 min read

There are many players in pharmaceutical pricing, from drug manufacturers to PBMs and pharmacies. Who should take the lead?

Business & Regulation Business Practice

05/05/2023 | Rob Coker | 4 min read

Hall Gregg, Chief Portfolio Officer at the Pistoia Alliance, discusses the transformative power of collaboration, innovation, and diversification

Business & Regulation Profession

04/17/2023 | Stephanie Vine

The wait is over. Our annual celebration of the pharma industry’s most influential individuals has returned!

Manufacture Bioprocessing - Upstream & Downstream

04/04/2023 | Adam Pinkert, Áine Brennan | 6 min read

How the thoughtful adoption of new technology can both problem-solve and future- proof critical processes in biomanufacturing

Business & Regulation Digital Technologies

03/15/2023 | Jason Boyd, Simon Meffan-Main | 4 min read

A new class of modern cloud systems promises the next step change in QC productivity and data integrity.

Business & Regulation Business Practice

03/14/2023 | Stephanie Vine | 4 min read

What does social media have to say about Eli Lilly’s insulin price reduction?

Business & Regulation Business Practice

03/06/2023 | Rainer Lichtenberger | 8 min read

What are the lessons we must learn from the COVID-19 pandemic?